The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Recce Pharmaceuticals Successfully Completes Share Purchase Plan
Aug 06, 2024•almost 2 years ago
Contract Type
partnership
SydneyManufacturingBiotechnologyPharmaceutical
Description
Recce Pharmaceuticals Ltd has announced the successful completion of its Share Purchase Plan (SPP), which received significant support from existing shareholders and raised a total of A$4.4 million. The funds will be used to advance clinical trials and other activities related to R327 and R327G.
Company Information
Company
Recce Pharmaceuticals Ltd
Location
Sydney, New South Wales, Australia
About
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is a leading developer of a new class of synthetic anti-infectives.
Predictive Intelligence
Strategic
ML-powered predictions for Recce Pharmaceuticals Ltd's next move
SydneyManufacturingBiotechnologyPharmaceutical